I'm LongbridgeAI, I can summarize articles.Arteris, Inc. launched FlexGen Multi-Die NoC IP to extend non-coherent connectivity across die boundaries, complementing its Ncore offering. Targeting AI/HPC chiplet designs, it supports UCIe standards and claims up to a 50% reduction in PHY area, power, and I/O. The solution is available for early access, with ecosystem validations from AMD, Cadence, and Synopsys.
Arteris, Inc. launched FlexGen Multi-Die NoC IP to extend non-coherent connectivity across die boundaries and complement its Ncore Multi-Die offering. The expanded solution is available to early access partners and strategic customers.
Material Details
| # | Detail | AI Analyst View |
|---|---|---|
| 1 | Launches FlexGen Multi-Die NoC IP | New product targets fast-growing chiplet AI/HPC designs, a key demand driver for IP licensing. |
| 2 | Extends NoC across UCIe die links | Supports industry-standard UCIe, easing adoption and partner interoperability. |
| 3 | Bidirectional over single UCIe PHY | Claims up to 50% cut in PHY area, power, I/O—value prop for cost/perf-sensitive chips. |
| 4 | Focus on non-coherent AI/HPC | Targets high-growth segments beyond cache-coherent data center designs. |
| 5 | Early access now available | Near-term pipeline indicator; timing suggests potential bookings ahead. |
| 6 | Ecosystem validations cited | Mentions AMD, Cadence, Synopsys, etc., signaling credibility and potential demand. |
Context by AI Analyst
This is a strategy push to capture chiplet adoption, aligning with AI/HPC demand and extending Arteris’ NoC leadership into multi-die. For this to be a larger catalyst, watch for design wins, revenue contribution in guidance, and partner tape-outs using FlexGen.
Based on the original press release from Arteris, Inc. distributed by GlobeNewswire.